<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00944359</url>
  </required_header>
  <id_info>
    <org_study_id>222218</org_study_id>
    <secondary_id>Zinc 7-20</secondary_id>
    <nct_id>NCT00944359</nct_id>
  </id_info>
  <brief_title>Impact of Preventive and Therapeutic Zinc Supplementation Programs Among Young Children</brief_title>
  <official_title>Community-based Intervention Trial to Compare the Impact of Preventive and Therapeutic Zinc Supplementation Programs Among Young Children in Burkina Faso</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Davis</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Universit√© Polytechnique de Bobo-Dioulasso</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Helen Keller International</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Thrasher Research Fund</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Canadian International Development Agency</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, Davis</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Zinc supplementation can either be provided in a lower daily dose to prevent zinc deficiency
      or in a higher dose for 10-14 days as part of the treatment of diarrhea. It is important to
      determine how best to integrate programs designed either to prevent zinc deficiency or to
      treat diarrhea.

      The overall objective of this project is to determine the most effective approach to prevent
      zinc deficiency and treat diarrhea, such that a single approach could provide the maximal
      beneficial impact on the health and nutritional status of young children and greatest
      simplicity of implementation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a single-center cluster- and household-randomized, partially masked, community-based
      efficacy trial of zinc supplementation. The study sample consists of 5 study groups in one
      region, with 34 clusters randomly assigned to 3 types of intervention communities.

      Communities will be randomly assigned to 1) early intervention communities, 2) later
      intervention communities, 3) non-intervention communities. Within each intervention cluster,
      children will be randomly assigned to the intervention group at the household level. Children
      aged 6-27 months at enrollment will be eligible. The study duration is 12 months.

      The investigators will assess the relative impact of daily preventive zinc supplementation (7
      mg zinc/d for one year), intermittent preventive supplementation (10 mg zinc/d for 10 days
      every three months for one year), and zinc treatment during episodes of diarrhea (20 mg
      zinc/d for 10 days beginning with each episode of diarrhea during one year). Outcomes that
      will be assessed include the incidence and duration of all episodes of diarrhea, the
      incidence of malaria, physical growth, and (in a sub-group) biochemical indicators of zinc,
      iron and vitamin A status.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2010</start_date>
  <completion_date type="Actual">February 2012</completion_date>
  <primary_completion_date type="Actual">February 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in length and length-for-age Z-score</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in weight and weight-for-age</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of diarrhea and laboratory-confirmed malaria</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in plasma zinc concentration</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of stunting, underweight, and wasting</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in hemoglobin and iron status</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">7680</enrollment>
  <condition>Zinc Deficiency</condition>
  <condition>Diarrhea</condition>
  <condition>Malaria</condition>
  <arm_group>
    <arm_group_label>Daily preventive Zn; placebo treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>7 mg zinc per day for 12 months and placebo supplement during diarrhea episode</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Therapeutic Zn; daily placebo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>20 mg of zinc for 10 days during episodes of diarrhea and daily placebo supplement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intermittent Zn; placebo treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>10 mg zinc for 10 days every 3 months, daily placebo during 80 days of 3 months period and placebo during diarrhea episode</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Surveillance control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Surveillance control group will be randomly assigned to intervention groups every 3 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-intervention</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard care provided by health system</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Daily preventive Zn; placebo treatment</intervention_name>
    <description>7 mg zinc / day and placebo supplement during diarrhea episodes</description>
    <arm_group_label>Daily preventive Zn; placebo treatment</arm_group_label>
    <other_name>Nutriset preventive zinc and therapeutic placebo supplement</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Therapeutic Zn; daily placebo</intervention_name>
    <description>20 mg zinc / day for 10 days during diarrhea episodes and daily placebo supplement</description>
    <arm_group_label>Therapeutic Zn; daily placebo</arm_group_label>
    <other_name>Nutriset ZinCfant</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Intermittent Zn; placebo treatment</intervention_name>
    <description>10 mg zinc for 10 days every 3 months, placebo supplements daily for all other days during 12 months; placebo supplements during diarrhea episodes</description>
    <arm_group_label>Intermittent Zn; placebo treatment</arm_group_label>
    <other_name>Nutriset zinc supplement</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Surveillance control group</intervention_name>
    <description>Active weekly morbidity surveillance for 3 months. New surveillance control group will be randomly assigned to intervention groups every 3 months</description>
    <arm_group_label>Surveillance control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  6-27 months of age

          -  Plan to remain in study area for 1 year

        Exclusion Criteria:

          -  Evidence of congenital abnormalities and chronic infection

          -  Severe anemia and severe acute malnutrition

          -  Consumption of micronutrient supplementation including zinc
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>27 Months</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kenneth H Brown, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Davis</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institut de Recherche en Science de la Sante</name>
      <address>
        <city>Bobo-Dioulasso</city>
        <country>Burkina Faso</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Burkina Faso</country>
  </location_countries>
  <verification_date>December 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 21, 2009</study_first_submitted>
  <study_first_submitted_qc>July 21, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 23, 2009</study_first_posted>
  <last_update_submitted>December 7, 2012</last_update_submitted>
  <last_update_submitted_qc>December 7, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 11, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>zinc supplementation</keyword>
  <keyword>diarrhea management</keyword>
  <keyword>zinc deficiency</keyword>
  <keyword>malaria</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Malaria</mesh_term>
    <mesh_term>Diarrhea</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Zinc</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

